Welcome to our dedicated page for RH SEC filings (Ticker: RH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RH’s luxury galleries are breathtaking, but the real story for investors lives inside its SEC filings. Membership revenue shifts, inventory commitments on bespoke sofas, and long-term gallery leases are buried across hundreds of pages. Finding them is tough—especially when the next 8-K drops while you’re still skimming last quarter’s numbers.
Our platform delivers every document the moment it hits EDGAR, from an RH quarterly earnings report 10-Q filing that details supply-chain impacts to an RH proxy statement executive compensation section that clarifies stock-based pay. Need to track RH insider trading Form 4 transactions? We surface RH Form 4 insider transactions real-time and translate footnotes into plain English. AI-powered summaries turn dense language into clear takeaways—perfect for understanding RH SEC documents with AI and getting an RH annual report 10-K simplified.
Whether you’re monitoring RH executive stock transactions Form 4, scanning an RH 8-K material events explained alert, or seeking deeper RH earnings report filing analysis, Stock Titan equips you with:
- AI highlights of key metrics—gross margin changes, gallery pipeline, membership trends
- Side-by-side quarterly comparisons that cut research time in half
- Real-time email or SMS alerts any time a filing hits the wire
- Downloadable data tables for fast modeling
Stop wading through technical disclosures. Get every RH SEC filing explained simply, as soon as it’s filed.
AT&T Inc. (T) – Form 4 insider filing: Director Cindy B. Taylor reported an automatic, in-plan acquisition of 6,219.765 deferred stock units (DSUs) on 06/30/2025 under the company’s Non-Employee Director Stock and Deferral Plan. Each DSU represents the economic value of one common share and is settled in cash after the director leaves the board. The reference price recorded for the underlying common stock was $28.94.
Following the transaction, Taylor’s direct equity holdings remain at 5,718 common shares and 320 Series C depositary shares, while her indirect derivative position increases to 196,964.0096 DSUs held through the benefit plan. No shares were sold or disposed of, and there were no option exercises or other derivative conversions disclosed.
The filing indicates continued alignment between the director and shareholder interests but does not represent a material change to AT&T’s overall share structure or insiders’ cumulative ownership.
On 06/26/2025, RH (ticker: RH) filed a Form 4 reporting that director Kathleen C. Mitic received an award of 670 shares of RH common stock at a cost basis of $0.00. The filing states that the restricted stock will vest in full one year from the grant date. After the grant, Mitic’s direct beneficial ownership rises to 12,056 shares. No sales, derivative securities, or Rule 10b5-1 plan transactions were disclosed.
RH (NYSE: RH) Form 4 filing dated 06/30/2025 discloses that independent director Mark S. Demilio received an equity grant of 670 restricted shares on 06/26/2025. The award vests in full one year from the grant date and was recorded at a $0 acquisition price, reflecting standard director compensation rather than an open-market purchase. Following the grant, Mr. Demilio’s total beneficial ownership rises to 42,056 RH common shares, comprising 12,717 shares held directly and 29,339 shares held indirectly through two family trusts. No derivative securities were reported. The filing indicates continued alignment between the director’s personal stake and shareholder interests, but it does not involve cash outlay or signal a market-driven buying decision.
RH (NYSE: RH) Form 4 filing dated 06/30/2025 discloses that independent director Mark S. Demilio received an equity grant of 670 restricted shares on 06/26/2025. The award vests in full one year from the grant date and was recorded at a $0 acquisition price, reflecting standard director compensation rather than an open-market purchase. Following the grant, Mr. Demilio’s total beneficial ownership rises to 42,056 RH common shares, comprising 12,717 shares held directly and 29,339 shares held indirectly through two family trusts. No derivative securities were reported. The filing indicates continued alignment between the director’s personal stake and shareholder interests, but it does not involve cash outlay or signal a market-driven buying decision.
RH (NYSE: RH) Form 4 filing dated 06/30/2025 discloses that independent director Mark S. Demilio received an equity grant of 670 restricted shares on 06/26/2025. The award vests in full one year from the grant date and was recorded at a $0 acquisition price, reflecting standard director compensation rather than an open-market purchase. Following the grant, Mr. Demilio’s total beneficial ownership rises to 42,056 RH common shares, comprising 12,717 shares held directly and 29,339 shares held indirectly through two family trusts. No derivative securities were reported. The filing indicates continued alignment between the director’s personal stake and shareholder interests, but it does not involve cash outlay or signal a market-driven buying decision.
RH (NYSE: RH) Form 4 filing dated 06/30/2025 discloses that independent director Mark S. Demilio received an equity grant of 670 restricted shares on 06/26/2025. The award vests in full one year from the grant date and was recorded at a $0 acquisition price, reflecting standard director compensation rather than an open-market purchase. Following the grant, Mr. Demilio’s total beneficial ownership rises to 42,056 RH common shares, comprising 12,717 shares held directly and 29,339 shares held indirectly through two family trusts. No derivative securities were reported. The filing indicates continued alignment between the director’s personal stake and shareholder interests, but it does not involve cash outlay or signal a market-driven buying decision.
RH (NYSE: RH) Form 4 filing dated 06/30/2025 discloses that independent director Mark S. Demilio received an equity grant of 670 restricted shares on 06/26/2025. The award vests in full one year from the grant date and was recorded at a $0 acquisition price, reflecting standard director compensation rather than an open-market purchase. Following the grant, Mr. Demilio’s total beneficial ownership rises to 42,056 RH common shares, comprising 12,717 shares held directly and 29,339 shares held indirectly through two family trusts. No derivative securities were reported. The filing indicates continued alignment between the director’s personal stake and shareholder interests, but it does not involve cash outlay or signal a market-driven buying decision.
RH (NYSE: RH) Form 4 filing dated 06/30/2025 discloses that independent director Mark S. Demilio received an equity grant of 670 restricted shares on 06/26/2025. The award vests in full one year from the grant date and was recorded at a $0 acquisition price, reflecting standard director compensation rather than an open-market purchase. Following the grant, Mr. Demilio’s total beneficial ownership rises to 42,056 RH common shares, comprising 12,717 shares held directly and 29,339 shares held indirectly through two family trusts. No derivative securities were reported. The filing indicates continued alignment between the director’s personal stake and shareholder interests, but it does not involve cash outlay or signal a market-driven buying decision.